tiprankstipranks
Trending News
More News >

EUNICE 5MIO - New Portfolio

Eunice Musyoka

EUNICE 5MIO
Individual Investor
Ranked #224,016 out of 825,627 TipRanks' Investors
Success Rate
70%
21 out of 30
profitable transactions
Average Return
28.19%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 9.01%
6-Month Return-
12-Month Return-
YTD Return▲ 28.80%
Total Return▲ 28.80%

Best Trade

Opened at
Closed at-
Gain▲ 373.29%

Bio

Performance

12.88%0-12.88%
▼ 6.38%
▼ 5.57%
Mar 2025
▲ 0.80%
▼ 0.87%
Apr 2025
▲ 11.63%
▲ 6.28%
May 2025
▲ 9.25%
▲ 5.14%
▼ 1.31%
Jun 2025
▲ 7.60%
▲ 2.30%
▼ 0.82%
Jul 2025
▲ 2.76%
▲ 2.05%
▲ 8.09%
Aug 2025
▲ 12.88%
▲ 3.56%
▲ 12.28%
Sep 2025
▲ 10.60%
▲ 3.13%
▲ 8.43%
Oct 2025
TipRanks AverageS&P 500Investor Portfolio
▼ 6.38%▼ 5.57%
▲ 0.80%▼ 0.87%
▲ 11.63%▲ 6.28%
▲ 9.25%▲ 5.14%▼ 1.31%
▲ 7.60%▲ 2.30%▼ 0.82%
▲ 2.76%▲ 2.05%▲ 8.09%
▲ 12.88%▲ 3.56%▲ 12.28%
▲ 10.60%▲ 3.13%▲ 8.43%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Red Cat Holdings
0%
▼ 24.07%
1
Open
Oct 04, 2025
AeroVironment
0%
▲ 36.40%
1
Open
Sep 19, 2025
Urogen Pharma
0%
▲ 12.11%
1
Open
Jul 24, 2025
Galaxy Digital
0%
▲ 16.93%
1
Open
Jul 24, 2025
Novo Nordisk
3.69%
▼ 32.19%
2
Buy
Jun 18, 2025
Sagimet Biosciences, Inc. Class A
0%
▲ 19.77%
1
Open
Jun 17, 2025
aTyr Pharma
0%
▼ 81.32%
1
Open
Jun 17, 2025
uniQure
0%
▲ 373.29%
1
Open
Jun 17, 2025
BridgeBio Pharma
0%
▲ 60.97%
1
Open
Jun 17, 2025
Alumis Inc.
0%
▲ 53.67%
1
Open
Jun 16, 2025
Sarepta Therapeutics
0%
▲ 15.66%
1
Open
Jun 16, 2025
AppLovin
0%
▲ 69.10%
1
Open
Jun 16, 2025
Brookfield Infrastructure
0%
▲ 5.93%
1
Open
Jun 16, 2025
Teva Pharmaceutical
0%
▲ 13.03%
1
Open
Jun 16, 2025
O'Reilly Auto
5.57%
▲ 5.77%
1
Open
Jun 12, 2025
FiscalNote Holdings
3.53%
▼ 34.78%
1
Open
Jun 12, 2025
Arcturus Therapeutics
4.14%
▼ 21.84%
1
Open
Jun 12, 2025
Taysha Gene Therapies
9.73%
▲ 88.30%
1
Open
Jun 12, 2025
HIVE Digital Technologies
14.5%
▲ 185.64%
1
Open
Jun 12, 2025
Phathom Pharmaceuticals
7.8%
▲ 35.00%
1
Open
Jun 12, 2025